📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
518 analysed today
FollowTelegram
518
Today
149,919
All-time analysed
42,971
Positive
6,669
Negative
91,572
Neutral
8,639
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
386 announcements match the current filters (relevance ≥ 5).
SPARC Board Approves ₹600 Crore Fundraise via Preferential Warrant Issue to Promoters
The board of Sun Pharma Advanced Research Company (SPARC) has approved a preferential issue of 3,85,10,000 convertible warrants to its promoter group entity, Shanghvi Finance Private Limited. The issue price is set at ₹155.80 per warrant, aggregating to approximately ₹600 crore. This capital infusion will see the promoter holding increase from 42.28% to 48.40% upon full conversion. Additionally, the company has introduced a new Employee Stock Option Scheme (ESOP 2026) covering 50 lakh shares to retain key talent.
Key Highlights
Preferential issuance of 3.85 crore warrants to promoter group at ₹155.80 per unit
Total fundraise of ₹599.99 crore with 25% (₹38.95 per warrant) payable upfront
Promoter shareholding to rise by 6.12% to reach 48.40% post-conversion
Approval of SPARC ESOP Scheme 2026 involving 50,00,000 equity shares (1.54% of capital)
Extraordinary General Meeting (EGM) scheduled for February 9, 2026, for shareholder approval
👀 What to Watch
The promoter's decision to increase their stake at a specific price point signals strong confidence in the company's long-term R&D prospects. Investors should monitor the utilization of these funds towards clinical trial progress and the upcoming EGM voting results.
Apeejay Surrendra Park Hotels Expands into Bihar with New Patna Property
Apeejay Surrendra Park Hotels Limited (ASPHL) has announced its first foray into Bihar with the launch of 'Zone Connect by The Park' in Patna. This city resort is strategically located 17 km from Jay Prakash International Airport and 9 km from Danapur Railway Station, targeting both business and leisure travelers. The property features significant event infrastructure with a capacity to host up to 1,000 guests, positioning it for the lucrative wedding and corporate event market. This move aligns with the company's strategy to expand its upper mid-scale footprint in high-potential Tier 2 and Tier 3 cities.
Key Highlights
First hotel launch in Bihar under the 'Zone Connect by The Park' brand.
Strategic location 17 km from Jay Prakash International Airport and 7.7 km from AIIMS Patna.
Large-scale event capacity for up to 1,000 guests across indoor and outdoor spaces.
Comprehensive amenities including Café C, The Bakery, Vitalia Spa, and a signature swimming pool.
Partnership with Ramanujam Resorts Pvt Ltd for development and operations.
👀 What to Watch
Investors should view this as a positive step in the company's asset-light and geographic diversification strategy. Monitor the ramp-up of occupancy and the brand's ability to command premium pricing in the Patna market.
SPARC Eyes $100M+ PRV Gain and Advances Oncology Pipeline in Strategic Reset
SPARC is refocusing its R&D on Oncology and Immunology following a strategic reset of its clinical pipeline. A major near-term catalyst is a favorable court ruling regarding a Pediatric Rare Disease Voucher (PRV), which could be worth over $100 million if the appeal window closes without a challenge in late January 2026. The company is also advancing SBO-154 (MUC1 ADC) into its third dose cohort and expects Phase 1B data for its Alopecia Areata treatment, SCD-153, by Q4 2026. To manage costs, SPARC is utilizing 'NewCo' structures and seeking partners for late-stage trials like Vodobatinib in CML.
Key Highlights
Potential $100 million+ cash inflow from Pediatric Rare Disease Voucher (PRV) following favorable court ruling against the FDA.
SBO-154 (MUC1 ADC) advanced to Cohort 3 in Phase 1 trials, approaching pharmacologically relevant doses.
SCD-153 for Alopecia Areata Phase 1B safety and preliminary efficacy data expected by Q4 2026.
Strategic shift to 'NewCo' models for assets like SCO-155 to reduce internal R&D risk and capital burden.
Vodobatinib (CML) program being evaluated for alternative structures or partnerships due to high costs of pivotal trials.
👀 What to Watch
Investors should closely watch for the expiration of the PRV appeal window in late January 2026, as a confirmed voucher would provide a massive non-dilutive cash infusion. Long-term value depends on the Q4 2026 data readouts for the immunology and oncology programs.
Park Medi World Acquires 250-Bed Krishna Super-speciality Hospital for ₹40 Crore
Park Medi World Limited has successfully acquired 100% shareholding of Mahip Hospitals Private Limited, which operates the 250-bed Krishna Super-speciality Hospital in Bathinda, for ₹40 crore. The company had been managing the facility since July 2025 and has now transitioned to full ownership to drive operational synergies. The target hospital demonstrated strong growth, with turnover rising from ₹7.73 crore in FY24 to ₹16 crore in FY25. This acquisition is a strategic step toward the company's goal of reaching a total capacity of 5,260 beds by March 2028.
Key Highlights
Acquisition of 100% stake in Mahip Hospitals Private Limited for an all-cash consideration of ₹40 crore.
Adds 250 beds (including 70 ICU beds) to Park Group's current capacity of 3,250 beds.
Target entity turnover grew significantly from ₹7.73 crore in FY24 to ₹16 crore in FY25.
Strategic shift from a management-only model to full ownership of the Bathinda facility.
Supports the company's aggressive expansion roadmap to reach 5,260 beds by March 2028.
👀 What to Watch
Investors should view this as a positive expansion move that strengthens the company's cluster-based growth in North India. Monitor the company's progress toward its 2028 bed-capacity target as a key valuation driver.
Park Medi World Acquires Krishna Super-speciality Hospital for INR 40 Crore
Park Medi World Limited has approved the 100% acquisition of Mahip Hospitals Private Limited, which operates the 250-bed Krishna Super-speciality Hospital in Bathinda. The acquisition is valued at an aggregate cash consideration of up to INR 40 crore. The target hospital has shown rapid growth, with turnover increasing from INR 7.73 crore in FY24 to INR 16.00 crore in FY25. This acquisition is a strategic step toward the company's goal of reaching a total capacity of 5,260 beds by March 2028.
Key Highlights
Acquisition of 100% stake in a 250-bed super-speciality facility for a maximum of INR 40 crore.
Target revenue grew by approximately 107% year-on-year to INR 16 crore in FY 2024-25.
The facility includes 70 ICU beds and modular operation theatres, strengthening regional infrastructure.
Park Medi World has been managing the hospital's operations since July 2025, ensuring a smooth transition.
Supports the company's long-term expansion plan to reach 5,260 beds by March 2028.
👀 What to Watch
Investors should view this as a positive growth move that expands the company's footprint and bed capacity. Monitor the impact of this acquisition on the company's consolidated revenue and margins in the coming quarters.
Paradeep Phosphates Seeks Approval to Increase Borrowing Limit to ₹20,000 Crore
Paradeep Phosphates Limited has issued a postal ballot notice seeking shareholder approval for a significant increase in its borrowing capacity to ₹20,000 crore. This new limit, which supersedes the 2022 resolution, is intended to fund working capital, capital asset acquisitions, and other business requirements through various debt instruments. The company is also seeking ratification for the cost auditor's remuneration of ₹5 lakh and the appointment of Mr. Akshay Poddar as a Non-Executive Director. E-voting for these resolutions will take place between January 4 and February 2, 2026.
Key Highlights
Proposed increase in borrowing limit to ₹20,000 crore, including loans, debentures, and foreign currency bonds.
Authorization sought to create mortgages or charges on company assets to secure the expanded debt limits.
Ratification of ₹5,00,000 remuneration for Cost Auditor M/s. S. S. Sonthalia & Co. for FY 2025-26.
Appointment of Mr. Akshay Poddar as a Non-Executive Director to the Board.
Remote e-voting period scheduled from January 4, 2026, to February 2, 2026.
👀 What to Watch
Investors should monitor the company's upcoming capital expenditure plans and leverage levels, as the massive increase in borrowing capacity suggests major expansion or acquisition plans. The appointment of a promoter-group director indicates continued strategic alignment with the Adventz Group.
SPARC to Host R&D Day on Jan 8, 2026, to Provide Strategic Pipeline Updates
Sun Pharma Advanced Research Company (SPARC) has scheduled an R&D Day for January 8, 2026, at 4:00 PM IST. The company will provide strategic updates on its prioritized programs and the progress of its innovative drug pipeline. As a research-focused entity, these updates are critical for assessing the company's long-term valuation and clinical trial success. A management presentation will be accessible via a dedicated webcast link during the audio conference.
Key Highlights
R&D Day scheduled for January 8, 2026, at 4:00 PM IST via audio conference.
Strategic updates to be provided on prioritized programs and innovative pipeline progress.
Management presentation link to be active on the day of the call for investor access.
Universal dial-in numbers provided: +91 22 6280 1278 and +91 22 7115 8179.
👀 What to Watch
Investors should monitor the January 8 call for specific updates on clinical trial timelines and potential licensing deals. The stock may experience volatility based on the perceived progress of key drug candidates.
Paradeep Phosphates Lists 22.16 Cr New Shares Following Merger with MCFL
Paradeep Phosphates Limited has received trading approval for 22,16,23,331 new equity shares of Rs. 10 each. These shares were allotted to shareholders of Mangalore Chemicals & Fertilizers Limited (MCFL) as part of the court-approved Scheme of Amalgamation. The approval was granted by both NSE and BSE on December 30, 2025. This marks the final procedural step in the merger process, effectively consolidating the two fertilizer businesses under one listed entity.
Key Highlights
Listing of 22,16,23,331 new equity shares of face value Rs. 10 each.
Trading approval received from NSE and BSE on December 30, 2025.
Shares issued pursuant to the Scheme of Amalgamation with Mangalore Chemicals & Fertilizers Limited.
The move completes the formal integration of the two entities into Paradeep Phosphates.
👀 What to Watch
Investors should monitor the combined entity's quarterly performance to assess synergy benefits and the impact of equity dilution on Earnings Per Share (EPS). Existing MCFL shareholders should check their demat accounts for the credited Paradeep shares.
Paradeep Phosphates to Enter Power Generation; Amends MOA Object Clause
Paradeep Phosphates Limited has approved an amendment to its Memorandum of Association (MOA) to include power generation and distribution as a main business object. The company intends to generate, purchase, and sell electrical energy from both conventional and non-conventional sources, including waste heat recovery systems. This strategic move allows the company to supply surplus power to state utilities and open market buyers, potentially creating a new revenue stream. The amendment also aligns the company's MOA with the Companies Act, 2013, and is currently subject to shareholder approval.
Key Highlights
Board approved insertion of sub-clause (iv) in Clause III(A) to permit power generation and distribution activities.
Focus on utilizing waste heat recovery systems to improve operational efficiency and energy self-sufficiency.
Authorization to sell surplus power to State utilities and open market buyers under applicable regulations.
Adoption of a new set of MOA to ensure full compliance with the Companies Act, 2013.
Decision taken via circular resolution on December 31, 2025, pending shareholder ratification.
👀 What to Watch
Investors should view this as a positive long-term strategic shift that could lower energy costs and diversify revenue. Monitor future CAPEX announcements related to power infrastructure and waste heat recovery projects.
Paramount Communications Promoters Acquire 1.5 Lakh Shares via Open Market
Promoters Sanjay Aggarwal and Sandeep Aggarwal purchased a combined 150,000 equity shares of Paramount Communications on December 29, 2025. Each promoter acquired 75,000 shares through open market transactions, representing a total investment of approximately ₹60 lakhs. This acquisition has increased the total promoter group shareholding from 49.07% to 49.12%. Such insider buying is typically interpreted as a sign of management's confidence in the company's long-term value and growth prospects.
Key Highlights
Promoters Sanjay and Sandeep Aggarwal purchased 75,000 shares each, totaling 150,000 shares.
Total promoter group holding increased by 0.05%, moving from 49.07% to 49.12%.
The transactions were executed on the NSE at a combined value of approximately ₹60.07 lakhs.
The acquisition was conducted via open market purchases on December 29, 2025, under SEBI PIT and SAST regulations.
👀 What to Watch
This insider buying reflects management's positive outlook on the company's future; investors may consider this a supportive factor for the stock's valuation and long-term stability.
Uniparts India Reports Fire at Ludhiana Plant; Surface Finishing Operations Disrupted
Uniparts India has reported a fire incident at its SKG Engineering plant in Ludhiana, Punjab, which occurred on the night of December 27, 2025. While there were no human casualties, surface finishing operations have been halted, leading to a temporary disruption in production. The company is mitigating the impact by utilizing its other manufacturing facilities to fulfill customer orders. While the plant is fully insured, the total financial loss is still being assessed by the company and insurance providers.
Key Highlights
Fire incident occurred at the SKG Engineering plant in Ludhiana on December 27, 2025, at 10:30 PM
Zero human casualties or injuries reported; fire was contained promptly
Surface finishing operations disrupted, with production being diverted to other company facilities
Plant is adequately insured, and the insurance company has been notified for damage assessment
👀 What to Watch
Investors should monitor the timeline for the restoration of normal operations and the final insurance claim amount. The company's ability to shift production to other plants suggests the impact on customer delivery may be limited.
Uniparts India Proposes Revision in WTD Remuneration to ₹3.83 Crore CTC
Uniparts India Limited has issued a postal ballot notice to seek shareholder approval for the revision of remuneration for Ms. Tanushree Bagrodia, Whole Time Director. The proposed total Cost to Company (CTC) is ₹3.83 crore per annum, effective from January 1, 2026, for her remaining tenure until November 2027. The proposal includes a fixed salary of ₹2.84 crore and a performance-linked incentive of ₹0.95 crore. Notably, the company is seeking a special resolution as total managerial remuneration may exceed the statutory limit of 11% of net profits.
Key Highlights
Proposed total annual CTC of ₹3,82,75,627 for Whole Time Director Ms. Tanushree Bagrodia.
Remuneration structure consists of ₹2.84 crore fixed salary and ₹94.67 lakh performance-linked incentive.
Provision for an annual increment of up to 10% in CTC subject to Board and NRC approval.
Special resolution required as total managerial pay may exceed 10-11% of the company's net profits.
Remote e-voting period is set from December 28, 2025, to January 26, 2026.
👀 What to Watch
Investors should assess if the proposed remuneration hike is justified by the company's financial performance and if the potential breach of the 11% net profit cap for managerial pay is acceptable given current growth trends.
Paras Defence Extends Timeline for 58.02% Stake Sale in Ayatti Innovative to March 2026
Paras Defence and Space Technologies has extended the deadline for the divestment of its 58.02% stake in subsidiary Ayatti Innovative Private Limited. The transaction, originally expected to conclude by December 31, 2025, is now slated for completion by March 31, 2026, due to ongoing due diligence by prospective buyers. Ayatti is currently a non-performing unit, reporting zero turnover and a negative net worth of Rs. 2.55 crore in FY 23-24. The company will disclose the final consideration and buyer details once the definitive agreement is signed.
Key Highlights
Divestment involves 15,20,000 equity shares representing a 58.02% stake in Ayatti Innovative.
Completion timeline extended by three months to March 31, 2026, pending due diligence.
Ayatti Innovative contributed NIL revenue to consolidated turnover in FY 23-24.
The subsidiary had a negative net worth of Rs. 2.55 crore as of March 31, 2024.
Transaction is confirmed to be with non-promoter entities and is not a related party transaction.
👀 What to Watch
Investors should monitor the final sale consideration as the exit from a loss-making, zero-revenue subsidiary is fundamentally positive for the company's consolidated balance sheet. The delay is administrative and does not currently signal a deal failure.
ASPHL Debuts in Kerala with Three Luxury Boutique Properties
Apeejay Surrendra Park Hotels Limited (ASPHL) has announced its entry into the Kerala market by adding three boutique properties to its luxury brand, THE Park Collection. The properties include the 17-room heritage hotel The Malabar House in Fort Kochi, the lakefront retreat Purity in Alappuzha, and the premium houseboat Discovery. This expansion aligns with the company's strategy to grow its presence in high-yield leisure destinations with heritage and design-led assets. Management expects these additions to be value-accretive, leveraging strong year-round domestic and international demand in Kerala.
Key Highlights
Marks ASPHL's first entry into the Kerala leisure market with three boutique assets
The Malabar House is a historic 17-room heritage hotel and a member of Relais & Châteaux
Includes Purity, a lakefront retreat in Alappuzha, and Discovery, a premium houseboat
Strategic focus on high-yielding, design-led properties with heritage value to drive RevPAR
Follows the recent acquisition of Zillion hotels in Mumbai, indicating an active growth phase
👀 What to Watch
Investors should view this as a positive step in diversifying the company's portfolio into high-margin leisure segments. Monitor the occupancy rates and contribution to the bottom line from these new assets in upcoming quarterly reports.
Park Medi World Acquires 200-Bed Febris Hospital for Rs 50.68 Crore
Park Medi World Limited, through its subsidiary Blue Heavens Health Care, has acquired 100% of Durha Vitrak Private Limited, which owns the 200-bed Febris Multi-speciality Hospital in Narela, Delhi. The acquisition was executed via the NCLT insolvency resolution process for a total consideration of Rs 50.68 crore. This facility, spanning 1,10,000 sq ft, has been non-operational since 2019 and will now be integrated into the Park Group network. The move is a key part of the company's strategy to expand its total capacity from 3,250 beds to 5,260 beds by March 2028.
Key Highlights
Acquisition of 100% stake in Durha Vitrak Private Limited for a maximum consideration of Rs 50.68 crore.
Adds a 200-bed multi-speciality hospital facility covering 1,10,000 sq ft in North Delhi.
Acquired through the Corporate Insolvency Resolution Process (CIRP) under NCLT approval.
Target facility has been non-operational since 2019, providing a turnaround opportunity for Park Group.
Supports the group's aggressive expansion goal to reach 5,260 beds across North India by March 2028.
👀 What to Watch
Investors should monitor the timeline for operationalizing the 200 beds and the subsequent ramp-up in occupancy. The acquisition at a distressed price via NCLT is value-accretive, but the immediate focus will be on the capital expenditure required to restart the facility.
Park Hotels Acquires Boutique Properties 'Purity' and 'The Malabar House' in Kerala
Apeejay Surrendra Park Hotels has signed agreements to acquire 100% of THALI Hotels and Destinations and Fishermans Grove Resorts, alongside at least 90.96% of Cochin Residency Private Limited. These acquisitions include the 'Purity' lakefront property, the 'Discovery' luxury houseboat, and 'The Malabar House' boutique hotel in Fort Kochi. The combined FY25 turnover of the revenue-generating targets (THALI and CRPL) was approximately INR 7.43 crore. This strategic move significantly strengthens the company's footprint in Kerala's high-end boutique hospitality market.
Key Highlights
Acquisition of 100% stake in THALI Hotels and Destinations and Fishermans Grove Resorts for the 'Purity' property and 'Discovery' houseboat.
Acquisition of at least 90.96% stake in Cochin Residency Private Limited, which owns the premium 'The Malabar House' in Fort Kochi.
Target entities THALI and CRPL reported FY25 turnovers of INR 2.46 crore and INR 4.97 crore respectively.
The transactions involve cash consideration with final pricing subject to closing adjustments as per the Share Purchase Agreements.
Acquired properties will be consolidated into the company's financial statements upon completion of the transactions.
👀 What to Watch
Investors should view this as a positive expansion into the high-margin boutique tourism segment in Kerala. Monitor the impact of these acquisitions on the company's consolidated occupancy rates and RevPAR in future earnings reports.
BIL Vyapar Ltd (Binani Industries) Schedules Committee of Creditors Meeting for Dec 19, 2025
BIL Vyapar Limited, formerly known as Binani Industries Limited, has scheduled a meeting of its Committee of Creditors (CoC) for December 19, 2025. This follows the initiation of the Corporate Insolvency Resolution Process (CIRP) by the NCLT via an order dated November 13, 2025. The company's management and assets are currently under the control of Interim Resolution Professional (IRP) Subodh Kumar Agrawal. This meeting is a critical step in the insolvency process to determine the company's future resolution or liquidation path.
Key Highlights
Committee of Creditors (CoC) meeting scheduled for December 19, 2025
Company placed under Corporate Insolvency Resolution Process (CIRP) effective November 13, 2025
Affairs and assets are being managed by IRP Subodh Kumar Agrawal (Reg No: IBBI/IPA-001/IP-P00087/2017-18/10183)
Disclosure made under Regulation 30 of SEBI (LODR) Regulations, 2015
NCLT order for insolvency was received by the company on November 21, 2025
👀 What to Watch
Investors should exercise extreme caution as equity value is typically significantly diluted or wiped out during insolvency proceedings. Monitor the CoC meeting outcomes for any proposed resolution plans or potential liquidation updates.
Apar Industries: CEO Shashi Amin Resigns, Effective Dec 12, 2025
Apar Industries Limited announced the resignation of Mr. Shashi Amin, Chief Executive Officer – Cable Solutions, effective December 12, 2025. Mr. Amin is leaving to pursue new opportunities outside the company. The company informed the exchange about this resignation under Regulation 30 of SEBI Listing Regulations. Investors should monitor the company's strategic direction and leadership transition following this change.
Key Highlights
Mr. Shashi Amin resigned as Chief Executive Officer – Cable Solutions.
Resignation is effective from December 12, 2025.
The resignation was disclosed under Regulation 30 of SEBI Listing Regulations.
👀 What to Watch
Investors should monitor the company's updates regarding the appointment of a new CEO and any potential impact on the company's cable solutions business. Review future earnings calls for further information.
NSE Appoints Merchant Banker for Fairness Opinion on Par Drugs Following SEBI Order
The National Stock Exchange (NSE) has appointed Kunvarji Finstock Private Limited to provide a fairness opinion regarding Par Drugs and Chemicals Limited, effective December 12, 2025. This move follows an Ex-Parte Interim Order issued by SEBI on September 15, 2025 (Order No. WTM/KV/CFID/CFID-SEC4/31660/2025-26). The company currently reports no quantifiable impact on its financial or operational activities due to this specific appointment. However, the requirement for a fairness opinion under a SEBI interim order suggests ongoing regulatory scrutiny that investors must track closely.
Key Highlights
NSE appointed Kunvarji Finstock Private Limited as merchant banker on Dec 12, 2025
Action taken in response to SEBI Ex-Parte Interim Order dated Sept 15, 2025
The merchant banker will provide a fairness opinion as directed by SEBI
Company states no immediate monetary impact on financial or operational activities
👀 What to Watch
Maintain a watchful stance as the fairness opinion could reveal underlying valuation or governance issues. Avoid aggressive positions until SEBI's final findings are released.
Apar Industries: CEO of Cable Solutions, Shashi Amin, Resigns
Apar Industries Limited announced the resignation of Mr. Shashi Amin, Chief Executive Officer – Cable Solutions, effective from the close of business hours on December 12, 2025. Mr. Amin resigned to pursue new opportunities outside the company. The company acknowledged his services and wished him success in his future endeavors. Investors should monitor the company's strategy for filling this key leadership role and any potential impact on the Cable Solutions business segment.
Key Highlights
Mr. Shashi Amin, Chief Executive Officer – Cable Solutions, resigned.
Resignation is effective from December 12, 2025.
Mr. Amin resigned to pursue new challenges and opportunities outside the Company.
👀 What to Watch
Investors should monitor the transition plan for the Cable Solutions division and any potential impact on the company's performance. Keep an eye on the appointment of a successor and any strategic shifts in the Cable Solutions business.
